Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 520 entries
Sorted by: Best Match Show Resources per page
Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size.

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 1164829
Clin Pharmacol Ther. 1975 Oct;18(4):491-505. doi: 10.1002/cpt1975184491.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther. 1975;18(4):491-505doi: 10.1002/cpt1975184491.
Feinstein, A. R. (1975). Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clinical pharmacology and therapeutics, 18(4), 491-505. https://doi.org/10.1002/cpt1975184491
Feinstein, A R. "Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size." Clinical pharmacology and therapeutics vol. 18,4 (1975): 491-505. doi: https://doi.org/10.1002/cpt1975184491
Feinstein AR. Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther. 1975 Oct;18(4):491-505. doi: 10.1002/cpt1975184491. PMID: 1164829.
Copy Download .nbib Format: NLM
Updating of a method for causality assessment of adverse drug reactions.

International journal of clinical pharmacology, therapy, and toxicology

Venulet J, Ciucci AG, Berneker GC.
PMID: 3781677
Int J Clin Pharmacol Ther Toxicol. 1986 Oct;24(10):559-68.

The paper represents an update of a method of standardized assessment of causality that was published in 1980. Because of experience that was gained in the meantime, weighting of certain types of information was modified and several weighting tables...

Cite
Venulet J, Ciucci AG, Berneker GC. Updating of a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol. 1986;24(10):559-68
Venulet, J., Ciucci, A. G., & Berneker, G. C. (1986). Updating of a method for causality assessment of adverse drug reactions. International journal of clinical pharmacology, therapy, and toxicology, 24(10), 559-68.
Venulet, J, et al. "Updating of a method for causality assessment of adverse drug reactions." International journal of clinical pharmacology, therapy, and toxicology vol. 24,10 (1986): 559-68.
Venulet J, Ciucci AG, Berneker GC. Updating of a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol. 1986 Oct;24(10):559-68. PMID: 3781677.
Copy Download .nbib Format: NLM
The clinical value of FDA class C drugs approved from 1981 to 1988.

Clinical pharmacology and therapeutics

Yasuda SU, Woosley RL.
PMID: 1458766
Clin Pharmacol Ther. 1992 Dec;52(6):577-82. doi: 10.1038/clpt.1992.194.

No abstract available.

Cite
Yasuda SU, Woosley RL. The clinical value of FDA class C drugs approved from 1981 to 1988. Clin Pharmacol Ther. 1992;52(6):577-82doi: 10.1038/clpt.1992.194.
Yasuda, S. U., & Woosley, R. L. (1992). The clinical value of FDA class C drugs approved from 1981 to 1988. Clinical pharmacology and therapeutics, 52(6), 577-82. https://doi.org/10.1038/clpt.1992.194
Yasuda, S U, and Woosley, R L. "The clinical value of FDA class C drugs approved from 1981 to 1988." Clinical pharmacology and therapeutics vol. 52,6 (1992): 577-82. doi: https://doi.org/10.1038/clpt.1992.194
Yasuda SU, Woosley RL. The clinical value of FDA class C drugs approved from 1981 to 1988. Clin Pharmacol Ther. 1992 Dec;52(6):577-82. doi: 10.1038/clpt.1992.194. PMID: 1458766.
Copy Download .nbib Format: NLM
Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication.

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 985637
Clin Pharmacol Ther. 1976 Nov;20(5):617-31. doi: 10.1002/cpt1976205617.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clin Pharmacol Ther. 1976;20(5):617-31doi: 10.1002/cpt1976205617.
Feinstein, A. R. (1976). Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clinical pharmacology and therapeutics, 20(5), 617-31. https://doi.org/10.1002/cpt1976205617
Feinstein, A R. "Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication." Clinical pharmacology and therapeutics vol. 20,5 (1976): 617-31. doi: https://doi.org/10.1002/cpt1976205617
Feinstein AR. Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clin Pharmacol Ther. 1976 Nov;20(5):617-31. doi: 10.1002/cpt1976205617. PMID: 985637.
Copy Download .nbib Format: NLM
Clinical biostatistics. XXVII. The derangements of the 'range of normal'.

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 4827470
Clin Pharmacol Ther. 1974 May;15(5):528-40. doi: 10.1002/cpt1974155528.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. XXVII. The derangements of the 'range of normal'. Clin Pharmacol Ther. 1974;15(5):528-40doi: 10.1002/cpt1974155528.
Feinstein, A. R. (1974). Clinical biostatistics. XXVII. The derangements of the 'range of normal'. Clinical pharmacology and therapeutics, 15(5), 528-40. https://doi.org/10.1002/cpt1974155528
Feinstein, A R. "Clinical biostatistics. XXVII. The derangements of the 'range of normal'." Clinical pharmacology and therapeutics vol. 15,5 (1974): 528-40. doi: https://doi.org/10.1002/cpt1974155528
Feinstein AR. Clinical biostatistics. XXVII. The derangements of the 'range of normal'. Clin Pharmacol Ther. 1974 May;15(5):528-40. doi: 10.1002/cpt1974155528. PMID: 4827470.
Copy Download .nbib Format: NLM
Statistical ward round. 16.

Clinical pharmacology and therapeutics

Mainland D.
PMID: 5793760
Clin Pharmacol Ther. 1969 Jul-Aug;10(4):576-86. doi: 10.1002/cpt1969104576.

No abstract available.

Cite
Mainland D. Statistical ward round. 16. Clin Pharmacol Ther. 1969;10(4):576-86doi: 10.1002/cpt1969104576.
Mainland, D. (1969). Statistical ward round. 16. Clinical pharmacology and therapeutics, 10(4), 576-86. https://doi.org/10.1002/cpt1969104576
Mainland, D. "Statistical ward round. 16." Clinical pharmacology and therapeutics vol. 10,4 (1969): 576-86. doi: https://doi.org/10.1002/cpt1969104576
Mainland D. Statistical ward round. 16. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):576-86. doi: 10.1002/cpt1969104576. PMID: 5793760.
Copy Download .nbib Format: NLM
Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2.

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 4729905
Clin Pharmacol Ther. 1973 Sep-Oct;14(5):898-915. doi: 10.1002/cpt1973145898.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2. Clin Pharmacol Ther. 1973;14(5):898-915doi: 10.1002/cpt1973145898.
Feinstein, A. R. (1973). Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2. Clinical pharmacology and therapeutics, 14(5), 898-915. https://doi.org/10.1002/cpt1973145898
Feinstein, A R. "Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2." Clinical pharmacology and therapeutics vol. 14,5 (1973): 898-915. doi: https://doi.org/10.1002/cpt1973145898
Feinstein AR. Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2. Clin Pharmacol Ther. 1973 Sep-Oct;14(5):898-915. doi: 10.1002/cpt1973145898. PMID: 4729905.
Copy Download .nbib Format: NLM
Clinical biostatistics. V. The architecture of clinical research (concluded).

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 5455637
Clin Pharmacol Ther. 1970 Sep-Oct;11(5):755-71. doi: 10.1002/cpt1970115755.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. V. The architecture of clinical research (concluded). Clin Pharmacol Ther. 1970;11(5):755-71doi: 10.1002/cpt1970115755.
Feinstein, A. R. (1970). Clinical biostatistics. V. The architecture of clinical research (concluded). Clinical pharmacology and therapeutics, 11(5), 755-71. https://doi.org/10.1002/cpt1970115755
Feinstein, A R. "Clinical biostatistics. V. The architecture of clinical research (concluded)." Clinical pharmacology and therapeutics vol. 11,5 (1970): 755-71. doi: https://doi.org/10.1002/cpt1970115755
Feinstein AR. Clinical biostatistics. V. The architecture of clinical research (concluded). Clin Pharmacol Ther. 1970 Sep-Oct;11(5):755-71. doi: 10.1002/cpt1970115755. PMID: 5455637.
Copy Download .nbib Format: NLM
FDA papers.

Clinical pharmacology and therapeutics

Ley HL, Modell W, Goddard JL.
PMID: 6054018
Clin Pharmacol Ther. 1967 Sep-Oct;8(5):749-54. doi: 10.1002/cpt196785749.

No abstract available.

Cite
Ley HL, Modell W, Goddard JL. FDA papers. Clin Pharmacol Ther. 1967;8(5):749-54doi: 10.1002/cpt196785749.
Ley, H. L., Modell, W., & Goddard, J. L. (1967). FDA papers. Clinical pharmacology and therapeutics, 8(5), 749-54. https://doi.org/10.1002/cpt196785749
Ley, H L, et al. "FDA papers." Clinical pharmacology and therapeutics vol. 8,5 (1967): 749-54. doi: https://doi.org/10.1002/cpt196785749
Ley HL, Modell W, Goddard JL. FDA papers. Clin Pharmacol Ther. 1967 Sep-Oct;8(5):749-54. doi: 10.1002/cpt196785749. PMID: 6054018.
Copy Download .nbib Format: NLM
Clinical biostatistics. XXXIII. On teaching statistics to medical students.

Clinical pharmacology and therapeutics

Feinstein AR.
PMID: 1149356
Clin Pharmacol Ther. 1975 Jul;18(1):121-6. doi: 10.1002/cpt1975181121.

No abstract available.

Cite
Feinstein AR. Clinical biostatistics. XXXIII. On teaching statistics to medical students. Clin Pharmacol Ther. 1975;18(1):121-6doi: 10.1002/cpt1975181121.
Feinstein, A. R. (1975). Clinical biostatistics. XXXIII. On teaching statistics to medical students. Clinical pharmacology and therapeutics, 18(1), 121-6. https://doi.org/10.1002/cpt1975181121
Feinstein, A R. "Clinical biostatistics. XXXIII. On teaching statistics to medical students." Clinical pharmacology and therapeutics vol. 18,1 (1975): 121-6. doi: https://doi.org/10.1002/cpt1975181121
Feinstein AR. Clinical biostatistics. XXXIII. On teaching statistics to medical students. Clin Pharmacol Ther. 1975 Jul;18(1):121-6. doi: 10.1002/cpt1975181121. PMID: 1149356.
Copy Download .nbib Format: NLM
Erratum.

International journal of clinical pharmacology and therapeutics

[No authors listed]
PMID: 26229998
Int J Clin Pharmacol Ther. 2015 May;53(5):414.

No abstract available.

Cite
Erratum. Int J Clin Pharmacol Ther. 2015;53(5):414
(2015). Erratum. International journal of clinical pharmacology and therapeutics, 53(5), 414.
"Erratum." International journal of clinical pharmacology and therapeutics vol. 53,5 (2015): 414.
Erratum. Int J Clin Pharmacol Ther. 2015 May;53(5):414. PMID: 26229998.
Copy Download .nbib Format: NLM
Novel approaches to address challenges in global drug development.

Clinical pharmacology and therapeutics

Smith BP, Huang SM.
PMID: 25669768
Clin Pharmacol Ther. 2015 Mar;97(3):196-9. doi: 10.1002/cpt.62. Epub 2015 Jan 22.

No abstract available.

Cite
Smith BP, Huang SM. Novel approaches to address challenges in global drug development. Clin Pharmacol Ther. 2015;97(3):196-9doi: 10.1002/cpt.62.
Smith, B. P., & Huang, S. M. (2015). Novel approaches to address challenges in global drug development. Clinical pharmacology and therapeutics, 97(3), 196-9. https://doi.org/10.1002/cpt.62
Smith, B P, and Huang, S-M. "Novel approaches to address challenges in global drug development." Clinical pharmacology and therapeutics vol. 97,3 (2015): 196-9. doi: https://doi.org/10.1002/cpt.62
Smith BP, Huang SM. Novel approaches to address challenges in global drug development. Clin Pharmacol Ther. 2015 Mar;97(3):196-9. doi: 10.1002/cpt.62. Epub 2015 Jan 22. PMID: 25669768.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 520 entries